Hidrosadenitis suppurativa

Hans Christian Ring; Peter Theut Riis; Mads Rasmussen; Trine Bertelsen; Nathalie Dufour; Louise Schøsler; Marie Nørgård Bjørn; Morten Bue Svendsen; Stine Simonsen; Kristian Kofoed; Simon Francis Thomsen; Gregor Be Jemec; Ditte Marie Lindhardt Saunte

doi:10.61409/V09240657

Hidrosadenitis suppurativa

Hans Christian Ring, Peter Theut Riis, Mads Rasmussen, Trine Bertelsen, Nathalie Dufour, Louise Schøsler, Marie Nørgård Bjørn, Morten Bue Svendsen, Stine Simonsen, Kristian Kofoed, Simon Francis Thomsen, Gregor Be Jemec, Ditte Marie Lindhardt Saunte

Institut for Klinisk Medicin - Hud- og Kønssygdomme

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Review › Forskning › peer review

Abstract

This review covers the recent literature on various treatment strategies, associated comorbidities and diagnosis of hidradenitis suppurativa (HS). HS is a chronic inflammatory skin condition that can pose a considerable challenge to treat. HS is associated with various comorbidities, such as metabolic syndrome and psychiatric disorders. Data demonstrates a significant diagnostic delay, which may contribute to the long preceding treatment history with multiple drug classes and treatment series before initiation of biologic therapy. Although adalimumab, secukinumab, and bimekizumab are the only approved biologics by EMA for moderate to severe HS, many promising biologics are currently being investigated for moderate to severe HS.

Bidragets oversatte titel	Hidradenitis suppurativa
Originalsprog	Dansk
Tidsskrift	Ugeskrift for laeger
Vol/bind	187
Nummer	14
ISSN	0041-5782
DOI	https://doi.org/10.61409/V09240657
Status	Udgivet - 31 mar. 2025

Emneord

Humans
Hidradenitis Suppurativa/drug therapy
Metabolic Syndrome/complications
Anti-Inflammatory Agents/therapeutic use

Adgang til dokumentet

10.61409/V09240657

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{2060af3d32954fe8aa6025b196cb7803,

title = "Hidrosadenitis suppurativa",

abstract = "This review covers the recent literature on various treatment strategies, associated comorbidities and diagnosis of hidradenitis suppurativa (HS). HS is a chronic inflammatory skin condition that can pose a considerable challenge to treat. HS is associated with various comorbidities, such as metabolic syndrome and psychiatric disorders. Data demonstrates a significant diagnostic delay, which may contribute to the long preceding treatment history with multiple drug classes and treatment series before initiation of biologic therapy. Although adalimumab, secukinumab, and bimekizumab are the only approved biologics by EMA for moderate to severe HS, many promising biologics are currently being investigated for moderate to severe HS.",

keywords = "Humans, Hidradenitis Suppurativa/drug therapy, Metabolic Syndrome/complications, Anti-Inflammatory Agents/therapeutic use",

author = "Ring, {Hans Christian} and Riis, {Peter Theut} and Mads Rasmussen and Trine Bertelsen and Nathalie Dufour and Louise Sch{\o}sler and Bj{\o}rn, {Marie N{\o}rg{\aa}rd} and Svendsen, {Morten Bue} and Stine Simonsen and Kristian Kofoed and Thomsen, {Simon Francis} and Jemec, {Gregor Be} and Saunte, {Ditte Marie Lindhardt}",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2025",

month = mar,

day = "31",

doi = "10.61409/V09240657",

language = "Dansk",

volume = "187",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "14",

}

TY - JOUR

T1 - Hidrosadenitis suppurativa

AU - Ring, Hans Christian

AU - Riis, Peter Theut

AU - Rasmussen, Mads

AU - Bertelsen, Trine

AU - Dufour, Nathalie

AU - Schøsler, Louise

AU - Bjørn, Marie Nørgård

AU - Svendsen, Morten Bue

AU - Simonsen, Stine

AU - Kofoed, Kristian

AU - Thomsen, Simon Francis

AU - Jemec, Gregor Be

AU - Saunte, Ditte Marie Lindhardt

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2025/3/31

Y1 - 2025/3/31

N2 - This review covers the recent literature on various treatment strategies, associated comorbidities and diagnosis of hidradenitis suppurativa (HS). HS is a chronic inflammatory skin condition that can pose a considerable challenge to treat. HS is associated with various comorbidities, such as metabolic syndrome and psychiatric disorders. Data demonstrates a significant diagnostic delay, which may contribute to the long preceding treatment history with multiple drug classes and treatment series before initiation of biologic therapy. Although adalimumab, secukinumab, and bimekizumab are the only approved biologics by EMA for moderate to severe HS, many promising biologics are currently being investigated for moderate to severe HS.

AB - This review covers the recent literature on various treatment strategies, associated comorbidities and diagnosis of hidradenitis suppurativa (HS). HS is a chronic inflammatory skin condition that can pose a considerable challenge to treat. HS is associated with various comorbidities, such as metabolic syndrome and psychiatric disorders. Data demonstrates a significant diagnostic delay, which may contribute to the long preceding treatment history with multiple drug classes and treatment series before initiation of biologic therapy. Although adalimumab, secukinumab, and bimekizumab are the only approved biologics by EMA for moderate to severe HS, many promising biologics are currently being investigated for moderate to severe HS.

KW - Humans

KW - Hidradenitis Suppurativa/drug therapy

KW - Metabolic Syndrome/complications

KW - Anti-Inflammatory Agents/therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=105002818491&partnerID=8YFLogxK

U2 - 10.61409/V09240657

DO - 10.61409/V09240657

M3 - Review

C2 - 40171910

SN - 0041-5782

VL - 187

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 14

ER -

Hidrosadenitis suppurativa

Abstract

Emneord

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater